___________________________________________________________________________________________________ Pete
Pharma
Pete Pharma’ s success is directly tied to the success of our partner pharmacies
the relationship at the point of sale.“ Unlike traditional B2B equipment manufacturers and suppliers, Pete Pharma’ s success is directly tied to the success of our partner pharmacies. Rather than relying on consumable sales, the company generates revenue through long-term partnerships, formulation
development, and ongoing innovation. If a printer sits idle, Pete Pharma doesn’ t succeed either.” Marc notes.
That structure changes the historic dynamic of compounding pharmaceuticals.“ It does not benefit Pete Pharma if a partner purchases a printer and it just sits there, as our revenue depends on the pharmacy actually using the printer.”
Installation is not the endpoint. It is where the work begins.“ The team stays involved, helping partners adapt workflows, train staff, and compound medications using our technology.” Another distinction is not locking partners into fixed systems.“ We will partner with a pharmacy to design or develop anything they want, but we never require you to use our proprietary products. It is a true partnership,” he highlights.
The 3D shift
Pharmaceutical 3D printing may still be emerging in the US, but it is not new. When
americanhealthcareleader. com 83